Return-to-Play for Elite Athletes With Genetic Heart Diseases Predisposing to Sudden Cardiac Death.
Katherine A MartinezJ Martijn BosAaron L BaggishDermot M PhelanKathryn E TobertDarrel B NewmanErica SchererBradley J PetekMichael J AckermanMatthew W MartinezPublished in: Journal of the American College of Cardiology (2023)
This is the first study describing the experience of athletes with a known SCD-predisposing GHD who are competing at the elite level. After careful evaluation, risk stratification, and tailoring of their GHD therapy, RTP following SDM appears associated with low, nonfatal events rates at elite levels of sport.